Advancing Cancer Treatment (ACT) provides funding for evidence-based efforts that improve understanding of and access to clinical trials for minority and underserved populations, facilitate participation in clinical trials, and improved clinical trial awareness.

Special Announcement: To Accelerate accrual of minority and underserved men to the PROMISE Registry, ACT invites proposals for the new Community Engagement Grant –. Up to ten grants will be awarded each with direct costs totaling up to $100,000 annually for two years plus 12% allowable indirect costs. Deadline: October 28, 2022.